Clinical Development Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
LIFE | D | aTyr Pharma, Inc. | 2.00 | |
CYTK | D | Cytokinetics, Incorporated | 1.80 | |
ICLR | C | ICON plc | 1.60 | |
MEDP | C | Medpace Holdings, Inc. | 1.46 | |
AXSM | C | Axsome Therapeutics, Inc. | 1.36 | |
LXRX | D | Lexicon Pharmaceuticals, Inc. | 1.13 | |
FBIO | F | Fortress Biotech, Inc. | 1.04 | |
NXTC | D | NextCure, Inc. | 0.60 | |
ALNY | F | Alnylam Pharmaceuticals, Inc. | 0.56 | |
ONCT | D | Oncternal Therapeutics, Inc. | 0.46 |
Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Information Technology Services Medical Devices
Related Stock Lists:
Biopharmaceutical
Biotechnology
Medicine
Cancer
Clinical Medicine
Clinical Trial
Colitis
Contract Research Organization
Contract Research Organizations
Immunotherapy
Life Sciences
Organ Systems
Solid Tumors
Ulcer
Ulcerative Colitis
Abdominal Pain
Acute Intermittent Porphyria
Acute Myeloid Leukemia
Alnylam Pharmaceuticals
Alpha 1 Antitrypsin Deficiency
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
EIRL | A | iShares MSCI Ireland Capped ETF | 20.73 | |
HELX | C | Franklin Genomic Advancements ETF | 10.47 | |
BBH | B | Market Vectors Biotech ETF | 6.96 | |
BBP | C | BioShares Biotechnology Products Fund | 6.44 | |
GERM | C | ETFMG Treatments Testing and Advancements ETF | 6.09 |
Compare ETFs
Related Industries:
Biotechnology
Diagnostics & Research
Drug Manufacturers - Specialty & Generic
Information Technology Services
Medical Devices
Related Stock Lists:
Biopharmaceutical
Biotechnology
Medicine
Cancer
Clinical Medicine
Clinical Trial
Colitis
Contract Research Organization
Contract Research Organizations
Immunotherapy
Life Sciences
Organ Systems
Solid Tumors
Ulcer
Ulcerative Colitis
Abdominal Pain
Acute Intermittent Porphyria
Acute Myeloid Leukemia
Alnylam Pharmaceuticals
Alpha 1 Antitrypsin Deficiency
- Clinical Development
Clinical development is the process of developing a new drug, medical device, or diagnostic test from the initial concept to the point of regulatory approval. It involves a series of steps, including preclinical research, clinical trials, regulatory review, and post-marketing surveillance. The goal of clinical development is to demonstrate the safety and efficacy of a product in order to obtain regulatory approval for marketing.
Recent Comments
- TraderMike on IZM
- SuccessfulGerbil321 on IZM
- TraderMike on IZM
- TraderMike on Today's Outage
- Crunching_The_Market on Today's Outage
From the Blog
Featured Articles